Biodegradable hollow mesoporous organosilica nanotheranostics (HMON) for multi-mode imaging and mild photo-therapeutic-induced mitochondrial damage on gastric cancer

BACKGROUND: CuS-modified hollow mesoporous organosilica nanoparticles (HMONCuS) have been preferred as non-invasive treatment for cancer, as near infrared (NIR)-induced photo-thermal effect (PTT) and/or photo-dynamic effect (PDT) could increase cancer cells' apoptosis. However, the certain role of HMON@CuS-produced-PTT&PDT inducing gastric cancer (GC) cells' mitochondrial damage, remained unclear. Moreover, theranostic efficiency of HMON@CuS might be well improved by applying multi-modal imaging, which could offer an optimal therapeutic region and time window. Herein, new nanotheranostics agents were reported by Gd doped HMON decorated by CuS nanocrystals (called HMON@CuS/Gd).

RESULTS: HMONCuS/Gd exhibited appropriate size distribution, good biocompatibility, L-Glutathione (GSH) responsive degradable properties, high photo-thermal conversion efficiency (82.4%) and a simultaneous reactive oxygen species (ROS) generation effect. Meanwhile, HMON@CuS/Gd could efficiently enter GC cells, induce combined mild PTT (43-45 °C) and PDT under mild NIR power density (0.8 W/cm2). Surprisingly, it was found that PTT might not be the only factor of cell apoptosis, as ROS induced by PDT also seemed playing an essential role. The NIR-induced ROS could attack mitochondrial transmembrane potentials (MTPs), then promote mitochondrial reactive oxygen species (mitoROS) production. Meanwhile, mitochondrial damage dramatically changed the expression of anti-apoptotic protein (Bcl-2) and pro-apoptotic protein (Bax). Since that, mitochondrial permeability transition pore (mPTP) was opened, followed by inducing more cytochrome c (Cyto C) releasing from mitochondria into cytosol, and finally activated caspase-9/caspase-3-depended cell apoptosis pathway. Our in vivo data also showed that HMON@CuS/Gd exhibited good fluorescence (FL) imaging (wrapping fluorescent agent), enhanced T1 imaging under magnetic resonance imaging (MRI) and infrared thermal (IRT) imaging capacities. Guided by FL/MRI/IRT trimodal imaging, HMON@CuS/Gd could selectively cause mild photo-therapy at cancer region, efficiently inhibit the growth of GC cells without evident systemic toxicity in vivo.

CONCLUSION: HMONCuS/Gd could serve as a promising multifunctional nanotheranostic platform and as a cancer photo-therapy agent through inducing mitochondrial dysfunction on GC.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

Journal of nanobiotechnology - 18(2020), 1 vom: 20. Juli, Seite 99

Sprache:

Englisch

Beteiligte Personen:

Guo, Weihong [VerfasserIn]
Chen, Zhian [VerfasserIn]
Chen, Jiajia [VerfasserIn]
Feng, Xiaoli [VerfasserIn]
Yang, Yang [VerfasserIn]
Huang, Huilin [VerfasserIn]
Liang, Yanrui [VerfasserIn]
Shen, Guodong [VerfasserIn]
Liang, Yu [VerfasserIn]
Peng, Chao [VerfasserIn]
Li, Yanbing [VerfasserIn]
Li, Guoxin [VerfasserIn]
Huang, Wenhua [VerfasserIn]
Zhao, Bingxia [VerfasserIn]
Hu, Yanfeng [VerfasserIn]

Links:

Volltext

Themen:

Antineoplastic Agents
Copper Sulfate
Hollow mesoporous organosilica nanoparticles (HMON)
Journal Article
LRX7AJ16DT
Mitochondrial damage
Multi-modal imaging
Organosilicon Compounds
Photo-dynamic therapy (PDT)
Photo-thermal therapy (PTT)

Anmerkungen:

Date Completed 22.02.2021

Date Revised 22.02.2021

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s12951-020-00653-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31266396X